Procedure-specific Risks of Thrombosis and Bleeding in Urological Cancer Surgery: Systematic Review and Meta-analysis
Kari A O Tikkinen1, Samantha Craigie2, Arnav Agarwal3
1Departments of Urology and Public Health, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
This study quantifies baseline risks for venous thromboembolism (VTE) and bleeding after urological cancer surgery. Extended thromboprophylaxis is recommended for high-VTE risk procedures like cystectomy, but not for low-risk prostatectomies.
Area of Science:
- Urology
- Oncology
- Vascular Surgery
Background:
- Pharmacological thromboprophylaxis balances venous thromboembolism (VTE) risk against bleeding risk.
- This balance is determined by baseline risks of VTE and bleeding without prophylaxis.
- Estimating these baseline risks is crucial for informed clinical decisions in urological cancer surgery.
Purpose of the Study:
- To estimate the baseline risk of symptomatic VTE after urological cancer surgery.
- To estimate the baseline risk of bleeding requiring reoperation after urological cancer surgery.
- To inform the decision-making process regarding thromboprophylaxis in urological cancer patients.
Main Methods:
- Systematic review and meta-analysis of contemporary observational studies.
- Inclusion of studies with low risk of bias, accounting for thromboprophylaxis use and follow-up duration.
- GRADE approach used to assess the quality of evidence for derived baseline risk estimates.
Main Results:
- Included 71 studies across 14 urological cancer procedures; evidence quality was moderate to very low.
- High VTE risk (2.6-11.6%) and low bleeding risk (0.3%) observed in cystectomies.
- VTE risk in prostatectomies varied widely (0.2-15.7%), with bleeding risk (0.1-1.0%); renal procedures showed VTE risk of 0.7-11.6% and bleeding risk of 0.1-2.0%.
Conclusions:
- Extended thromboprophylaxis is indicated for high-VTE risk procedures like open and robotic cystectomy.
- Routine extended thromboprophylaxis is not recommended for low-risk robotic prostatectomy without pelvic lymph node dissection (PLND).
- For procedures with intermediate risks, clinical decisions on thromboprophylaxis should consider patient values and preferences regarding VTE and bleeding.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Venous Thrombosis I: Introduction
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Peripheral Artery Disease V: Postoperative Nursing Management
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.


